XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development expenses $ 9,730 $ 12,653 $ 32,320 $ 24,228
General and administrative expenses 4,604 4,249 13,804 12,031
Total operating expenses 14,334 16,902 46,124 36,259
Loss from operations (14,334) (16,902) (46,124) (36,259)
Other income :        
Interest income and other, net 1,426 2,283 4,654 6,893
Total other income 1,426 2,283 4,654 6,893
Net loss $ (12,908) $ (14,619) $ (41,470) $ (29,366)
Net loss per share, basic (in dollars per share) $ (0.4) $ (0.45) $ (1.28) $ (0.95)
Net loss per share, diluted (in dollars per share) $ (0.4) $ (0.45) $ (1.28) $ (0.95)
Weighted-average shares outstanding, basic (in shares) 32,464,893 32,143,336 32,286,188 31,036,271
Weighted-average shares outstanding, diluted (in shares) 32,464,893 32,143,336 32,286,188 31,036,271
Other comprehensive income:        
Net loss $ (12,908) $ (14,619) $ (41,470) $ (29,366)
Net unrealized gain (loss) on marketable securities 41 464 (113) 411
Total comprehensive loss $ (12,867) $ (14,155) $ (41,583) $ (28,955)